| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Testosterone | 205 | 2024 | 2491 | 22.880 |
Why?
|
| Hypogonadism | 45 | 2024 | 805 | 10.250 |
Why?
|
| Androgens | 59 | 2023 | 1281 | 9.990 |
Why?
|
| Hormone Replacement Therapy | 40 | 2024 | 757 | 6.990 |
Why?
|
| Anabolic Agents | 14 | 2023 | 256 | 4.400 |
Why?
|
| Muscle Strength | 28 | 2024 | 640 | 4.340 |
Why?
|
| Mobility Limitation | 19 | 2021 | 409 | 4.240 |
Why?
|
| Sarcopenia | 17 | 2024 | 378 | 3.900 |
Why?
|
| Sex Hormone-Binding Globulin | 34 | 2024 | 553 | 3.530 |
Why?
|
| Muscle, Skeletal | 56 | 2023 | 4978 | 3.320 |
Why?
|
| Myostatin | 19 | 2024 | 129 | 3.260 |
Why?
|
| Receptors, Androgen | 20 | 2023 | 1089 | 2.810 |
Why?
|
| Body Composition | 34 | 2020 | 2462 | 2.770 |
Why?
|
| Hand Strength | 13 | 2023 | 466 | 2.540 |
Why?
|
| Aging | 48 | 2023 | 8744 | 2.390 |
Why?
|
| Dihydrotestosterone | 10 | 2024 | 195 | 2.220 |
Why?
|
| Estradiol | 25 | 2024 | 1951 | 2.170 |
Why?
|
| Erectile Dysfunction | 7 | 2024 | 437 | 2.140 |
Why?
|
| Estrone | 11 | 2022 | 234 | 2.030 |
Why?
|
| Accidental Falls | 10 | 2020 | 1080 | 1.730 |
Why?
|
| Erythropoiesis | 6 | 2020 | 691 | 1.700 |
Why?
|
| Gonadal Steroid Hormones | 12 | 2024 | 707 | 1.690 |
Why?
|
| NAD | 4 | 2024 | 618 | 1.650 |
Why?
|
| Endocrine System Diseases | 6 | 2019 | 250 | 1.590 |
Why?
|
| Dietary Proteins | 5 | 2021 | 960 | 1.470 |
Why?
|
| Double-Blind Method | 55 | 2024 | 12465 | 1.340 |
Why?
|
| Male | 255 | 2024 | 364719 | 1.310 |
Why?
|
| Tandem Mass Spectrometry | 8 | 2022 | 1197 | 1.270 |
Why?
|
| Chromatography, Liquid | 9 | 2022 | 996 | 1.250 |
Why?
|
| Aged | 154 | 2024 | 171504 | 1.240 |
Why?
|
| Performance-Enhancing Substances | 3 | 2017 | 30 | 1.110 |
Why?
|
| Doping in Sports | 3 | 2021 | 62 | 1.110 |
Why?
|
| Prostatic Neoplasms | 10 | 2024 | 11101 | 1.090 |
Why?
|
| Nicotinamide Mononucleotide | 2 | 2023 | 17 | 1.070 |
Why?
|
| Humans | 302 | 2024 | 768166 | 1.050 |
Why?
|
| Cardiovascular System | 4 | 2022 | 841 | 1.040 |
Why?
|
| Finasteride | 2 | 2017 | 86 | 1.040 |
Why?
|
| Cardiovascular Diseases | 24 | 2024 | 15662 | 1.010 |
Why?
|
| Anemia | 4 | 2023 | 1514 | 1.000 |
Why?
|
| Activin Receptors, Type II | 3 | 2017 | 122 | 1.000 |
Why?
|
| Body Dysmorphic Disorders | 3 | 2019 | 243 | 1.000 |
Why?
|
| Consensus | 10 | 2024 | 3212 | 0.980 |
Why?
|
| Diagnostic Techniques, Endocrine | 3 | 2018 | 43 | 0.970 |
Why?
|
| 5-alpha Reductase Inhibitors | 3 | 2017 | 112 | 0.970 |
Why?
|
| Independent Living | 12 | 2022 | 584 | 0.970 |
Why?
|
| Muscle Weakness | 5 | 2020 | 412 | 0.910 |
Why?
|
| Erythropoietin | 5 | 2016 | 718 | 0.870 |
Why?
|
| Growth Differentiation Factors | 6 | 2024 | 99 | 0.860 |
Why?
|
| Fatty Liver | 3 | 2023 | 809 | 0.850 |
Why?
|
| Human Growth Hormone | 9 | 2013 | 651 | 0.850 |
Why?
|
| Absorptiometry, Photon | 12 | 2024 | 1758 | 0.840 |
Why?
|
| Urinary Retention | 1 | 2023 | 101 | 0.840 |
Why?
|
| Satellite Cells, Skeletal Muscle | 5 | 2012 | 124 | 0.830 |
Why?
|
| National Institute on Aging (U.S.) | 1 | 2022 | 40 | 0.830 |
Why?
|
| Activities of Daily Living | 4 | 2021 | 2430 | 0.830 |
Why?
|
| Alopecia | 2 | 2017 | 416 | 0.800 |
Why?
|
| Reproduction | 4 | 2015 | 646 | 0.800 |
Why?
|
| Niacinamide | 1 | 2024 | 418 | 0.800 |
Why?
|
| Phosphodiesterase 5 Inhibitors | 2 | 2013 | 103 | 0.790 |
Why?
|
| Middle Aged | 111 | 2024 | 223492 | 0.760 |
Why?
|
| Polycythemia | 3 | 2013 | 124 | 0.760 |
Why?
|
| Simian Acquired Immunodeficiency Syndrome | 2 | 2017 | 545 | 0.760 |
Why?
|
| Insulin Resistance | 14 | 2023 | 3986 | 0.750 |
Why?
|
| Sexual Dysfunction, Physiological | 7 | 2018 | 364 | 0.750 |
Why?
|
| Exercise Test | 10 | 2020 | 2186 | 0.740 |
Why?
|
| Metabolome | 3 | 2024 | 1009 | 0.720 |
Why?
|
| Bone Density | 9 | 2024 | 3573 | 0.710 |
Why?
|
| Simian immunodeficiency virus | 2 | 2017 | 814 | 0.710 |
Why?
|
| Body Mass Index | 25 | 2024 | 13053 | 0.710 |
Why?
|
| Receptors, LDL | 3 | 2013 | 493 | 0.700 |
Why?
|
| Sulfones | 2 | 2013 | 448 | 0.690 |
Why?
|
| Endocrinology | 2 | 2018 | 443 | 0.690 |
Why?
|
| Klinefelter Syndrome | 1 | 2020 | 48 | 0.680 |
Why?
|
| Postmenopause | 11 | 2022 | 2518 | 0.670 |
Why?
|
| Transforming Growth Factor beta | 11 | 2023 | 1996 | 0.660 |
Why?
|
| Antimicrobial Cationic Peptides | 2 | 2013 | 352 | 0.660 |
Why?
|
| Prostate | 6 | 2024 | 1765 | 0.650 |
Why?
|
| Anemia, Iron-Deficiency | 2 | 2020 | 372 | 0.650 |
Why?
|
| HIV Wasting Syndrome | 3 | 2014 | 99 | 0.630 |
Why?
|
| Arteriosclerosis | 3 | 2013 | 1055 | 0.630 |
Why?
|
| Luteinizing Hormone | 10 | 2024 | 822 | 0.620 |
Why?
|
| Hemoglobins | 7 | 2023 | 1531 | 0.620 |
Why?
|
| Geriatric Assessment | 7 | 2020 | 1422 | 0.620 |
Why?
|
| Prostate-Specific Antigen | 7 | 2023 | 2463 | 0.620 |
Why?
|
| Gonadotropins | 3 | 2013 | 241 | 0.610 |
Why?
|
| Body Weight | 14 | 2023 | 4627 | 0.600 |
Why?
|
| Walking | 7 | 2021 | 1201 | 0.600 |
Why?
|
| Prediabetic State | 1 | 2024 | 548 | 0.600 |
Why?
|
| Muscle Fibers, Skeletal | 4 | 2007 | 553 | 0.590 |
Why?
|
| Veterans Health | 1 | 2019 | 216 | 0.590 |
Why?
|
| Physical Fitness | 4 | 2020 | 744 | 0.590 |
Why?
|
| Adipose Tissue | 13 | 2015 | 3329 | 0.590 |
Why?
|
| Quality of Life | 12 | 2023 | 13490 | 0.580 |
Why?
|
| Sexual Behavior | 8 | 2024 | 2197 | 0.580 |
Why?
|
| Behavior Therapy | 1 | 2023 | 886 | 0.580 |
Why?
|
| Fractures, Bone | 4 | 2024 | 2062 | 0.580 |
Why?
|
| Dose-Response Relationship, Drug | 24 | 2019 | 10760 | 0.560 |
Why?
|
| Patient Care Management | 1 | 2020 | 303 | 0.560 |
Why?
|
| Aged, 80 and over | 51 | 2024 | 59629 | 0.550 |
Why?
|
| Adipocytes | 5 | 2008 | 1197 | 0.550 |
Why?
|
| Exercise | 7 | 2023 | 5955 | 0.540 |
Why?
|
| Estrogens | 7 | 2022 | 1536 | 0.540 |
Why?
|
| Adult | 99 | 2024 | 223646 | 0.540 |
Why?
|
| Gels | 10 | 2024 | 423 | 0.530 |
Why?
|
| Hysterectomy | 4 | 2019 | 863 | 0.530 |
Why?
|
| Reference Values | 13 | 2022 | 4938 | 0.530 |
Why?
|
| Intra-Abdominal Fat | 2 | 2021 | 625 | 0.530 |
Why?
|
| Physical Endurance | 6 | 2009 | 369 | 0.520 |
Why?
|
| Spinal Cord Injuries | 1 | 2024 | 928 | 0.520 |
Why?
|
| Muscle Fatigue | 3 | 2008 | 96 | 0.520 |
Why?
|
| Eating | 1 | 2022 | 1542 | 0.500 |
Why?
|
| beta Catenin | 4 | 2012 | 1047 | 0.500 |
Why?
|
| Erythrocyte Deformability | 1 | 2015 | 55 | 0.490 |
Why?
|
| Disease Transmission, Infectious | 1 | 2020 | 560 | 0.490 |
Why?
|
| Body Fat Distribution | 2 | 2006 | 246 | 0.480 |
Why?
|
| Sexual Dysfunctions, Psychological | 1 | 2016 | 193 | 0.480 |
Why?
|
| Blood Viscosity | 1 | 2015 | 125 | 0.470 |
Why?
|
| Weight Loss | 8 | 2009 | 2721 | 0.470 |
Why?
|
| Sexuality | 3 | 2014 | 179 | 0.470 |
Why?
|
| Reproductive Medicine | 1 | 2016 | 99 | 0.470 |
Why?
|
| Neurodegenerative Diseases | 1 | 2023 | 1095 | 0.460 |
Why?
|
| Androgen Antagonists | 5 | 2023 | 1412 | 0.460 |
Why?
|
| Motor Activity | 7 | 2015 | 2711 | 0.450 |
Why?
|
| Follistatin | 6 | 2024 | 138 | 0.450 |
Why?
|
| Joints | 1 | 2015 | 324 | 0.450 |
Why?
|
| Prostatectomy | 1 | 2021 | 1786 | 0.430 |
Why?
|
| Leuprolide | 4 | 2010 | 313 | 0.430 |
Why?
|
| Bone Morphogenetic Proteins | 6 | 2024 | 845 | 0.430 |
Why?
|
| Receptors, Fc | 1 | 2017 | 537 | 0.430 |
Why?
|
| Epidemics | 1 | 2019 | 517 | 0.420 |
Why?
|
| Disabled Persons | 1 | 2023 | 1210 | 0.420 |
Why?
|
| Renal Dialysis | 1 | 2022 | 1791 | 0.420 |
Why?
|
| Growth Hormone | 3 | 2010 | 573 | 0.420 |
Why?
|
| Bone Resorption | 1 | 2017 | 728 | 0.420 |
Why?
|
| Immunoglobulin Fc Fragments | 1 | 2014 | 287 | 0.410 |
Why?
|
| Wnt Proteins | 2 | 2008 | 725 | 0.410 |
Why?
|
| Work Schedule Tolerance | 1 | 2016 | 553 | 0.400 |
Why?
|
| Administration, Cutaneous | 10 | 2020 | 716 | 0.400 |
Why?
|
| Piperazines | 2 | 2013 | 2554 | 0.400 |
Why?
|
| Azasteroids | 1 | 2012 | 37 | 0.390 |
Why?
|
| Hematocrit | 5 | 2014 | 623 | 0.390 |
Why?
|
| Overweight | 1 | 2023 | 2448 | 0.390 |
Why?
|
| Cross-Sectional Studies | 32 | 2024 | 26379 | 0.390 |
Why?
|
| Body Image | 1 | 2017 | 646 | 0.380 |
Why?
|
| Mitochondria, Muscle | 1 | 2012 | 172 | 0.380 |
Why?
|
| Cross Infection | 1 | 2020 | 1426 | 0.380 |
Why?
|
| Public Health | 2 | 2022 | 2679 | 0.380 |
Why?
|
| India | 17 | 2018 | 2334 | 0.380 |
Why?
|
| Female | 96 | 2024 | 397192 | 0.370 |
Why?
|
| Heart | 2 | 2023 | 4446 | 0.370 |
Why?
|
| Chemistry, Clinical | 1 | 2011 | 64 | 0.370 |
Why?
|
| Health Status | 4 | 2018 | 4091 | 0.370 |
Why?
|
| Hip Fractures | 4 | 2020 | 997 | 0.360 |
Why?
|
| Monocytes | 1 | 2020 | 2605 | 0.360 |
Why?
|
| Atherosclerosis | 5 | 2018 | 3433 | 0.360 |
Why?
|
| Patient-Centered Care | 1 | 2021 | 1444 | 0.360 |
Why?
|
| Certification | 1 | 2014 | 420 | 0.360 |
Why?
|
| Transsexualism | 4 | 2024 | 210 | 0.350 |
Why?
|
| Placebos | 10 | 2018 | 1667 | 0.350 |
Why?
|
| Depressive Disorder | 2 | 2024 | 3721 | 0.350 |
Why?
|
| Health Promotion | 1 | 2022 | 2210 | 0.350 |
Why?
|
| Gonadotropin-Releasing Hormone | 5 | 2008 | 1149 | 0.340 |
Why?
|
| Penile Erection | 3 | 2022 | 100 | 0.340 |
Why?
|
| Muscle Development | 6 | 2020 | 258 | 0.340 |
Why?
|
| Occupational Health | 1 | 2016 | 812 | 0.340 |
Why?
|
| Mice, Inbred C57BL | 16 | 2023 | 22379 | 0.340 |
Why?
|
| TCF Transcription Factors | 3 | 2008 | 138 | 0.340 |
Why?
|
| Erythrocytes | 3 | 2015 | 2418 | 0.340 |
Why?
|
| Obesity | 12 | 2023 | 13090 | 0.330 |
Why?
|
| Orchiectomy | 6 | 2015 | 466 | 0.330 |
Why?
|
| Societies, Medical | 3 | 2021 | 3968 | 0.330 |
Why?
|
| Sports | 3 | 2021 | 703 | 0.330 |
Why?
|
| Blood Platelets | 1 | 2020 | 2479 | 0.330 |
Why?
|
| Exercise Therapy | 4 | 2023 | 939 | 0.330 |
Why?
|
| Treatment Outcome | 28 | 2024 | 65371 | 0.330 |
Why?
|
| Adipogenesis | 3 | 2009 | 370 | 0.330 |
Why?
|
| Iron | 2 | 2020 | 1813 | 0.320 |
Why?
|
| Lipolysis | 2 | 2009 | 211 | 0.320 |
Why?
|
| Procollagen | 1 | 2009 | 189 | 0.320 |
Why?
|
| Animals | 48 | 2023 | 169246 | 0.310 |
Why?
|
| Puberty | 2 | 2009 | 501 | 0.310 |
Why?
|
| Regeneration | 2 | 2020 | 1524 | 0.310 |
Why?
|
| Pluripotent Stem Cells | 3 | 2004 | 809 | 0.300 |
Why?
|
| Hepatocytes | 2 | 2013 | 1247 | 0.300 |
Why?
|
| Dependovirus | 1 | 2013 | 720 | 0.300 |
Why?
|
| Nuclear Family | 1 | 2009 | 311 | 0.290 |
Why?
|
| Proteasome Endopeptidase Complex | 2 | 2013 | 1319 | 0.290 |
Why?
|
| Ligands | 5 | 2017 | 3284 | 0.290 |
Why?
|
| Depression | 4 | 2024 | 8230 | 0.290 |
Why?
|
| Hospitalization | 3 | 2024 | 10840 | 0.290 |
Why?
|
| Ritonavir | 1 | 2009 | 331 | 0.290 |
Why?
|
| Smad3 Protein | 1 | 2008 | 166 | 0.290 |
Why?
|
| Insulin | 9 | 2019 | 6607 | 0.290 |
Why?
|
| Neutrophils | 1 | 2020 | 3786 | 0.290 |
Why?
|
| Frail Elderly | 4 | 2019 | 781 | 0.280 |
Why?
|
| HIV Infections | 11 | 2021 | 17569 | 0.280 |
Why?
|
| HIV Protease Inhibitors | 1 | 2009 | 430 | 0.280 |
Why?
|
| Enzyme Inhibitors | 2 | 2017 | 3728 | 0.280 |
Why?
|
| Lipids | 9 | 2013 | 3343 | 0.280 |
Why?
|
| Educational Measurement | 1 | 2014 | 1260 | 0.280 |
Why?
|
| Sleep Initiation and Maintenance Disorders | 1 | 2016 | 1107 | 0.270 |
Why?
|
| Adiposity | 3 | 2012 | 1895 | 0.270 |
Why?
|
| Affect | 3 | 2018 | 1495 | 0.270 |
Why?
|
| Puberty, Delayed | 1 | 2007 | 124 | 0.270 |
Why?
|
| Dehydroepiandrosterone | 2 | 2006 | 259 | 0.270 |
Why?
|
| Libido | 5 | 2018 | 124 | 0.270 |
Why?
|
| Prevalence | 13 | 2023 | 15869 | 0.270 |
Why?
|
| Blood Glucose | 8 | 2024 | 6430 | 0.270 |
Why?
|
| Oxandrolone | 1 | 2006 | 24 | 0.260 |
Why?
|
| Muscular Atrophy | 3 | 2003 | 335 | 0.260 |
Why?
|
| Young Adult | 26 | 2024 | 60066 | 0.260 |
Why?
|
| Chromosomes, Human, Y | 1 | 2007 | 164 | 0.260 |
Why?
|
| Natriuretic Peptides | 3 | 2011 | 156 | 0.260 |
Why?
|
| Reference Standards | 2 | 2022 | 1014 | 0.260 |
Why?
|
| Thigh | 3 | 2020 | 238 | 0.260 |
Why?
|
| Hyperprolactinemia | 1 | 2007 | 124 | 0.260 |
Why?
|
| Phosphodiesterase Inhibitors | 1 | 2007 | 213 | 0.260 |
Why?
|
| Mice | 30 | 2023 | 82029 | 0.260 |
Why?
|
| Health Knowledge, Attitudes, Practice | 5 | 2014 | 4055 | 0.250 |
Why?
|
| Blood Chemical Analysis | 2 | 2018 | 435 | 0.250 |
Why?
|
| Nandrolone | 1 | 2005 | 16 | 0.250 |
Why?
|
| Autophagy | 1 | 2013 | 1349 | 0.250 |
Why?
|
| Wounds and Injuries | 1 | 2018 | 2517 | 0.250 |
Why?
|
| Recombinant Proteins | 5 | 2013 | 6514 | 0.250 |
Why?
|
| Fertility | 3 | 2021 | 771 | 0.250 |
Why?
|
| Risk Factors | 25 | 2024 | 74944 | 0.240 |
Why?
|
| Child of Impaired Parents | 1 | 2009 | 462 | 0.240 |
Why?
|
| Cause of Death | 5 | 2024 | 3721 | 0.240 |
Why?
|
| Risk Assessment | 10 | 2022 | 24315 | 0.240 |
Why?
|
| Abdominal Fat | 1 | 2006 | 220 | 0.240 |
Why?
|
| Gene Expression Regulation | 11 | 2018 | 11928 | 0.240 |
Why?
|
| United States | 22 | 2023 | 73039 | 0.240 |
Why?
|
| Mental Health | 2 | 2023 | 3275 | 0.240 |
Why?
|
| Androstenedione | 1 | 2004 | 132 | 0.240 |
Why?
|
| Cognition | 7 | 2019 | 7073 | 0.240 |
Why?
|
| Opioid-Related Disorders | 1 | 2019 | 2188 | 0.230 |
Why?
|
| Organ Size | 9 | 2015 | 2267 | 0.230 |
Why?
|
| Diabetes Complications | 2 | 2012 | 1320 | 0.230 |
Why?
|
| Weight Lifting | 3 | 2017 | 130 | 0.230 |
Why?
|
| Polycystic Ovary Syndrome | 1 | 2009 | 383 | 0.230 |
Why?
|
| Age Factors | 12 | 2024 | 18412 | 0.230 |
Why?
|
| Dietary Supplements | 3 | 2018 | 3445 | 0.230 |
Why?
|
| Infertility, Male | 1 | 2007 | 397 | 0.220 |
Why?
|
| Liver | 5 | 2013 | 7577 | 0.220 |
Why?
|
| Receptors, Transferrin | 2 | 2020 | 300 | 0.220 |
Why?
|
| Cell Nucleus | 5 | 2008 | 2885 | 0.220 |
Why?
|
| Pyrazines | 1 | 2009 | 1205 | 0.220 |
Why?
|
| Organ Specificity | 4 | 2016 | 1968 | 0.220 |
Why?
|
| Insulin-Like Growth Factor I | 8 | 2010 | 1942 | 0.220 |
Why?
|
| Muscle Proteins | 5 | 2012 | 1165 | 0.220 |
Why?
|
| Clinical Trials as Topic | 5 | 2023 | 8054 | 0.210 |
Why?
|
| Muscle Contraction | 3 | 2008 | 1209 | 0.210 |
Why?
|
| Biological Specimen Banks | 4 | 2022 | 788 | 0.210 |
Why?
|
| Leg | 3 | 2008 | 1088 | 0.210 |
Why?
|
| Fatigue | 3 | 2018 | 1557 | 0.210 |
Why?
|
| Hypertrophy | 3 | 2015 | 562 | 0.210 |
Why?
|
| Prostatic Diseases | 1 | 2003 | 57 | 0.210 |
Why?
|
| Incidence | 11 | 2024 | 21538 | 0.210 |
Why?
|
| 3-Oxo-5-alpha-Steroid 4-Dehydrogenase | 3 | 2012 | 74 | 0.210 |
Why?
|
| Evidence-Based Medicine | 4 | 2020 | 3706 | 0.200 |
Why?
|
| Myosin Heavy Chains | 5 | 2019 | 404 | 0.200 |
Why?
|
| Chromosome Deletion | 1 | 2007 | 1385 | 0.200 |
Why?
|
| Substance-Related Disorders | 1 | 2019 | 4423 | 0.200 |
Why?
|
| Randomized Controlled Trials as Topic | 8 | 2022 | 10399 | 0.200 |
Why?
|
| Mass Spectrometry | 3 | 2023 | 2202 | 0.200 |
Why?
|
| Population Groups | 1 | 2003 | 209 | 0.200 |
Why?
|
| Goiter, Endemic | 1 | 2001 | 3 | 0.200 |
Why?
|
| Heart Injuries | 1 | 2023 | 207 | 0.190 |
Why?
|
| Research Design | 4 | 2017 | 6211 | 0.190 |
Why?
|
| Chronic Disease | 3 | 2023 | 9384 | 0.190 |
Why?
|
| HIV-Associated Lipodystrophy Syndrome | 1 | 2003 | 138 | 0.190 |
Why?
|
| Education, Medical, Graduate | 1 | 2014 | 2420 | 0.190 |
Why?
|
| Spinal Fractures | 2 | 2019 | 710 | 0.190 |
Why?
|
| Reproductive Techniques | 1 | 2021 | 41 | 0.190 |
Why?
|
| Diabetes Mellitus, Type 2 | 8 | 2023 | 12252 | 0.190 |
Why?
|
| Oxygen Consumption | 3 | 2018 | 1880 | 0.190 |
Why?
|
| Biology | 1 | 2023 | 292 | 0.190 |
Why?
|
| Prenatal Exposure Delayed Effects | 3 | 2024 | 2538 | 0.190 |
Why?
|
| Iodine | 2 | 2001 | 285 | 0.190 |
Why?
|
| Peptide Fragments | 3 | 2011 | 5151 | 0.190 |
Why?
|
| Mesenchymal Stem Cells | 3 | 2009 | 1672 | 0.180 |
Why?
|
| Adolescent | 26 | 2024 | 89169 | 0.180 |
Why?
|
| Dehydroepiandrosterone Sulfate | 4 | 2011 | 241 | 0.180 |
Why?
|
| Life Style | 5 | 2024 | 3932 | 0.180 |
Why?
|
| Gene Expression | 7 | 2020 | 7598 | 0.180 |
Why?
|
| Radius | 1 | 2024 | 443 | 0.180 |
Why?
|
| HIV | 1 | 2008 | 1597 | 0.180 |
Why?
|
| Aryl Hydrocarbon Receptor Nuclear Translocator | 1 | 2020 | 37 | 0.180 |
Why?
|
| Sleep | 1 | 2016 | 4819 | 0.180 |
Why?
|
| Signal Transduction | 13 | 2023 | 23645 | 0.180 |
Why?
|
| Cell Differentiation | 10 | 2020 | 11669 | 0.180 |
Why?
|
| Sperm Retrieval | 1 | 2020 | 23 | 0.170 |
Why?
|
| Bone Marrow Cells | 1 | 2008 | 2414 | 0.170 |
Why?
|
| Erythrocyte Count | 1 | 2020 | 157 | 0.170 |
Why?
|
| Testosterone Congeners | 2 | 2023 | 62 | 0.170 |
Why?
|
| Erythroblasts | 1 | 2020 | 142 | 0.170 |
Why?
|
| Gene Deletion | 3 | 2019 | 2675 | 0.170 |
Why?
|
| Mortality | 3 | 2021 | 2911 | 0.170 |
Why?
|
| Patients | 2 | 2020 | 908 | 0.170 |
Why?
|
| National Institutes of Health (U.S.) | 1 | 2023 | 794 | 0.160 |
Why?
|
| Prospective Studies | 13 | 2023 | 54926 | 0.160 |
Why?
|
| Ovariectomy | 4 | 2015 | 613 | 0.160 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 7 | 2015 | 4580 | 0.160 |
Why?
|
| Nurse's Role | 1 | 2020 | 188 | 0.160 |
Why?
|
| Hormones | 3 | 2022 | 866 | 0.160 |
Why?
|
| GATA1 Transcription Factor | 1 | 2020 | 306 | 0.160 |
Why?
|
| Administration, Topical | 3 | 2024 | 703 | 0.160 |
Why?
|
| Macaca mulatta | 2 | 2017 | 2363 | 0.160 |
Why?
|
| Sex Education | 1 | 1999 | 94 | 0.160 |
Why?
|
| Estrogen Replacement Therapy | 3 | 2022 | 1209 | 0.160 |
Why?
|
| Cohort Studies | 14 | 2024 | 41754 | 0.160 |
Why?
|
| Depressive Disorder, Major | 1 | 2016 | 4818 | 0.160 |
Why?
|
| Erythroid Cells | 1 | 2020 | 237 | 0.160 |
Why?
|
| Patient Selection | 3 | 2018 | 4260 | 0.160 |
Why?
|
| Sports Medicine | 1 | 2021 | 239 | 0.160 |
Why?
|
| RNA, Messenger | 9 | 2015 | 12800 | 0.160 |
Why?
|
| Myocardial Infarction | 4 | 2023 | 11519 | 0.150 |
Why?
|
| Cholesterol, HDL | 2 | 2022 | 1820 | 0.150 |
Why?
|
| Inflammation | 3 | 2016 | 10873 | 0.150 |
Why?
|
| Clinical Competence | 1 | 2014 | 4858 | 0.150 |
Why?
|
| Poliovirus Vaccine, Oral | 1 | 1997 | 24 | 0.150 |
Why?
|
| Acquired Immunodeficiency Syndrome | 1 | 2006 | 2204 | 0.150 |
Why?
|
| Tibia | 1 | 2024 | 1076 | 0.150 |
Why?
|
| Transcortin | 1 | 2017 | 12 | 0.150 |
Why?
|
| Muscles | 2 | 2015 | 1582 | 0.150 |
Why?
|
| Aromatase | 1 | 2018 | 147 | 0.140 |
Why?
|
| Follicle Stimulating Hormone, Human | 2 | 2008 | 25 | 0.140 |
Why?
|
| Neoplasms | 3 | 2023 | 22371 | 0.140 |
Why?
|
| Controlled Clinical Trials as Topic | 1 | 2018 | 187 | 0.140 |
Why?
|
| Diet | 3 | 2018 | 8089 | 0.140 |
Why?
|
| Hip Joint | 1 | 2004 | 1018 | 0.140 |
Why?
|
| Cholesterol | 2 | 2023 | 2914 | 0.140 |
Why?
|
| Spleen | 2 | 2013 | 2295 | 0.140 |
Why?
|
| Recovery of Function | 2 | 2020 | 2981 | 0.140 |
Why?
|
| Smoke | 1 | 2019 | 242 | 0.140 |
Why?
|
| Soybean Proteins | 1 | 2017 | 55 | 0.140 |
Why?
|
| United States Department of Veterans Affairs | 3 | 2018 | 937 | 0.140 |
Why?
|
| Spine | 1 | 2004 | 1140 | 0.140 |
Why?
|
| Integrases | 1 | 2019 | 520 | 0.140 |
Why?
|
| Blood Transfusion | 1 | 2023 | 1309 | 0.140 |
Why?
|
| Self-Injurious Behavior | 1 | 2023 | 568 | 0.130 |
Why?
|
| Glucose | 2 | 2024 | 4352 | 0.130 |
Why?
|
| Immunization Schedule | 1 | 1997 | 228 | 0.130 |
Why?
|
| Maternal-Fetal Exchange | 1 | 2018 | 454 | 0.130 |
Why?
|
| Transcription Factor 7-Like 2 Protein | 2 | 2008 | 152 | 0.130 |
Why?
|
| Up-Regulation | 5 | 2014 | 4146 | 0.130 |
Why?
|
| Menopause | 3 | 2022 | 1656 | 0.130 |
Why?
|
| Gonadotrophs | 1 | 2016 | 19 | 0.130 |
Why?
|
| Natriuretic Peptide, Brain | 4 | 2012 | 1751 | 0.130 |
Why?
|
| Hydrocortisone | 1 | 2024 | 1841 | 0.130 |
Why?
|
| Femoral Fractures | 1 | 2019 | 376 | 0.130 |
Why?
|
| Women's Health | 1 | 2005 | 2082 | 0.130 |
Why?
|
| Carotid Arteries | 1 | 2020 | 942 | 0.130 |
Why?
|
| Fluoroimmunoassay | 2 | 2013 | 30 | 0.130 |
Why?
|
| Radioimmunoassay | 2 | 2013 | 863 | 0.130 |
Why?
|
| Severity of Illness Index | 6 | 2024 | 15948 | 0.120 |
Why?
|
| Internationality | 2 | 2011 | 1008 | 0.120 |
Why?
|
| Smad Proteins | 2 | 2013 | 157 | 0.120 |
Why?
|
| Myocytes, Cardiac | 2 | 2019 | 1681 | 0.120 |
Why?
|
| Extremities | 2 | 2015 | 870 | 0.120 |
Why?
|
| Minority Health | 1 | 2016 | 79 | 0.120 |
Why?
|
| Drug Labeling | 1 | 2017 | 250 | 0.120 |
Why?
|
| Hospitals, Veterans | 1 | 2017 | 395 | 0.120 |
Why?
|
| Veterans | 3 | 2018 | 2669 | 0.120 |
Why?
|
| Maternal-Child Health Centers | 1 | 1995 | 42 | 0.120 |
Why?
|
| Off-Label Use | 1 | 2016 | 185 | 0.120 |
Why?
|
| Self-Assessment | 1 | 2017 | 400 | 0.120 |
Why?
|
| Calcium | 3 | 2018 | 5792 | 0.120 |
Why?
|
| Transportation | 1 | 2016 | 217 | 0.120 |
Why?
|
| Health Status Disparities | 2 | 2017 | 1885 | 0.120 |
Why?
|
| Random Allocation | 2 | 2013 | 2396 | 0.120 |
Why?
|
| Drug Administration Schedule | 3 | 2010 | 4860 | 0.120 |
Why?
|
| Hypopituitarism | 2 | 2014 | 253 | 0.120 |
Why?
|
| Ankle Brachial Index | 2 | 2013 | 163 | 0.120 |
Why?
|
| Autistic Disorder | 1 | 2024 | 1240 | 0.120 |
Why?
|
| Infertility | 1 | 2021 | 655 | 0.120 |
Why?
|
| Gait | 4 | 2022 | 823 | 0.120 |
Why?
|
| Energy Intake | 2 | 2017 | 2146 | 0.120 |
Why?
|
| Follow-Up Studies | 8 | 2020 | 39348 | 0.110 |
Why?
|
| Attitude | 1 | 1999 | 771 | 0.110 |
Why?
|
| Eflornithine | 1 | 2013 | 31 | 0.110 |
Why?
|
| Impotence, Vasculogenic | 1 | 2013 | 13 | 0.110 |
Why?
|
| Heart Failure | 3 | 2024 | 11879 | 0.110 |
Why?
|
| Metabolism | 1 | 2015 | 193 | 0.110 |
Why?
|
| Ornithine Decarboxylase | 1 | 2013 | 63 | 0.110 |
Why?
|
| Cathepsin L | 1 | 2013 | 69 | 0.110 |
Why?
|
| Syndrome | 2 | 2010 | 3272 | 0.110 |
Why?
|
| Genes, Y-Linked | 1 | 2013 | 12 | 0.110 |
Why?
|
| Guidelines as Topic | 2 | 2010 | 1397 | 0.110 |
Why?
|
| Athletes | 1 | 2021 | 1162 | 0.110 |
Why?
|
| Massachusetts | 6 | 2013 | 8890 | 0.110 |
Why?
|
| Hypertension | 4 | 2019 | 8616 | 0.110 |
Why?
|
| Follicle Stimulating Hormone | 3 | 2016 | 727 | 0.110 |
Why?
|
| 3T3 Cells | 2 | 2005 | 1084 | 0.110 |
Why?
|
| Hair | 1 | 2017 | 508 | 0.110 |
Why?
|
| Malaria | 1 | 2003 | 1249 | 0.110 |
Why?
|
| Glucocorticoids | 4 | 2009 | 2167 | 0.110 |
Why?
|
| Thinness | 3 | 2011 | 483 | 0.110 |
Why?
|
| Cardiomyopathy, Dilated | 1 | 2019 | 843 | 0.110 |
Why?
|
| Anthropometry | 5 | 2020 | 1346 | 0.100 |
Why?
|
| Patient Compliance | 2 | 2018 | 2697 | 0.100 |
Why?
|
| Orgasm | 1 | 2012 | 62 | 0.100 |
Why?
|
| Growth | 1 | 1995 | 366 | 0.100 |
Why?
|
| Disability Evaluation | 1 | 2020 | 1835 | 0.100 |
Why?
|
| Erythrocyte Indices | 1 | 2013 | 143 | 0.100 |
Why?
|
| Erythroid Precursor Cells | 1 | 2013 | 211 | 0.100 |
Why?
|
| Muscle Fibers, Fast-Twitch | 2 | 2003 | 71 | 0.100 |
Why?
|
| Kinetics | 4 | 2011 | 6329 | 0.100 |
Why?
|
| Cobra Cardiotoxin Proteins | 1 | 2012 | 5 | 0.100 |
Why?
|
| Mice, Transgenic | 4 | 2013 | 9561 | 0.100 |
Why?
|
| Self Care | 1 | 2018 | 799 | 0.100 |
Why?
|
| Cytokines | 2 | 2013 | 7453 | 0.100 |
Why?
|
| Mice, Knockout | 5 | 2019 | 14488 | 0.100 |
Why?
|
| Drug Design | 2 | 2009 | 1046 | 0.100 |
Why?
|
| Disease Progression | 6 | 2020 | 13671 | 0.100 |
Why?
|
| Models, Chemical | 1 | 2014 | 611 | 0.100 |
Why?
|
| Hep G2 Cells | 1 | 2013 | 378 | 0.100 |
Why?
|
| Sebum | 1 | 2012 | 17 | 0.100 |
Why?
|
| Commerce | 1 | 2017 | 612 | 0.100 |
Why?
|
| Biomedical Research | 2 | 2019 | 3463 | 0.100 |
Why?
|
| Coitus | 1 | 2012 | 132 | 0.100 |
Why?
|
| Sex Factors | 5 | 2020 | 10632 | 0.100 |
Why?
|
| Bone Remodeling | 1 | 2015 | 583 | 0.100 |
Why?
|
| Transferrin | 1 | 2013 | 283 | 0.100 |
Why?
|
| Neural Cell Adhesion Molecules | 1 | 2012 | 122 | 0.100 |
Why?
|
| Down-Regulation | 2 | 2010 | 2937 | 0.100 |
Why?
|
| Patient Advocacy | 1 | 2014 | 362 | 0.100 |
Why?
|
| Drug Therapy, Combination | 4 | 2012 | 6316 | 0.100 |
Why?
|
| Cell Proliferation | 4 | 2012 | 10474 | 0.100 |
Why?
|
| Practice Guidelines as Topic | 5 | 2018 | 7454 | 0.100 |
Why?
|
| Plaque, Atherosclerotic | 2 | 2020 | 1551 | 0.100 |
Why?
|
| Voice | 1 | 2015 | 268 | 0.100 |
Why?
|
| Sensitivity and Specificity | 6 | 2020 | 14729 | 0.100 |
Why?
|
| Flutamide | 1 | 2012 | 95 | 0.090 |
Why?
|
| Teaching | 1 | 1999 | 1171 | 0.090 |
Why?
|
| Drug Utilization | 1 | 2017 | 1189 | 0.090 |
Why?
|
| Logistic Models | 4 | 2020 | 13290 | 0.090 |
Why?
|
| Tendons | 1 | 2015 | 556 | 0.090 |
Why?
|
| Models, Biological | 2 | 2009 | 9495 | 0.090 |
Why?
|
| Caloric Restriction | 1 | 2013 | 301 | 0.090 |
Why?
|
| Microscopy, Electron | 2 | 2006 | 2560 | 0.090 |
Why?
|
| K562 Cells | 1 | 2013 | 644 | 0.090 |
Why?
|
| Thermodynamics | 2 | 2011 | 591 | 0.090 |
Why?
|
| Pelvic Floor | 2 | 2019 | 138 | 0.090 |
Why?
|
| Coronary Artery Disease | 3 | 2020 | 6568 | 0.090 |
Why?
|
| Plasminogen Activator Inhibitor 1 | 1 | 2012 | 279 | 0.090 |
Why?
|
| Gene Expression Profiling | 1 | 2007 | 9538 | 0.090 |
Why?
|
| Nuclear Receptor Coactivators | 1 | 2011 | 62 | 0.090 |
Why?
|
| Statistics as Topic | 1 | 2017 | 2357 | 0.090 |
Why?
|
| Lumbar Vertebrae | 2 | 2018 | 1885 | 0.090 |
Why?
|
| Mutation | 2 | 2013 | 30238 | 0.090 |
Why?
|
| Transcription, Genetic | 3 | 2013 | 7608 | 0.090 |
Why?
|
| Workload | 1 | 2016 | 849 | 0.090 |
Why?
|
| Cell Count | 2 | 2006 | 1832 | 0.090 |
Why?
|
| Child Welfare | 1 | 1994 | 523 | 0.090 |
Why?
|
| Carrier Proteins | 1 | 2023 | 4937 | 0.090 |
Why?
|
| Skinfold Thickness | 1 | 1990 | 164 | 0.090 |
Why?
|
| Sex Reassignment Procedures | 2 | 2024 | 72 | 0.090 |
Why?
|
| Athletic Performance | 1 | 2011 | 113 | 0.090 |
Why?
|
| Europe | 1 | 2017 | 3436 | 0.090 |
Why?
|
| Workplace | 1 | 2016 | 873 | 0.090 |
Why?
|
| AMP-Activated Protein Kinases | 1 | 2013 | 596 | 0.090 |
Why?
|
| Time Factors | 6 | 2018 | 40218 | 0.090 |
Why?
|
| Quality Control | 1 | 2012 | 836 | 0.080 |
Why?
|
| Physicians | 2 | 2023 | 4598 | 0.080 |
Why?
|
| Anilino Naphthalenesulfonates | 1 | 2009 | 16 | 0.080 |
Why?
|
| Habits | 1 | 2010 | 148 | 0.080 |
Why?
|
| Community Health Services | 1 | 1995 | 659 | 0.080 |
Why?
|
| Memory Disorders | 1 | 2017 | 1200 | 0.080 |
Why?
|
| Executive Function | 2 | 2017 | 1401 | 0.080 |
Why?
|
| Coronary Vessels | 3 | 2016 | 3124 | 0.080 |
Why?
|
| Protein Multimerization | 1 | 2014 | 965 | 0.080 |
Why?
|
| Calorimetry | 1 | 2009 | 132 | 0.080 |
Why?
|
| Microscopy, Confocal | 2 | 2006 | 1972 | 0.080 |
Why?
|
| Cholestenone 5 alpha-Reductase | 1 | 2009 | 21 | 0.080 |
Why?
|
| Purines | 1 | 2012 | 615 | 0.080 |
Why?
|
| HIV-1 | 1 | 2006 | 6961 | 0.080 |
Why?
|
| Protein Precursors | 1 | 2013 | 1134 | 0.080 |
Why?
|
| Immunohistochemistry | 5 | 2006 | 11095 | 0.080 |
Why?
|
| Mass Screening | 2 | 2003 | 5458 | 0.080 |
Why?
|
| Cells, Cultured | 7 | 2011 | 19015 | 0.080 |
Why?
|
| Glycoprotein Hormones, alpha Subunit | 1 | 2008 | 95 | 0.080 |
Why?
|
| Longitudinal Studies | 8 | 2024 | 14783 | 0.080 |
Why?
|
| Analysis of Variance | 2 | 2010 | 6229 | 0.080 |
Why?
|
| Azoospermia | 1 | 2008 | 28 | 0.080 |
Why?
|
| Developing Countries | 1 | 2001 | 2910 | 0.080 |
Why?
|
| Minority Groups | 1 | 2016 | 1216 | 0.080 |
Why?
|
| Osteogenesis | 1 | 2015 | 1288 | 0.080 |
Why?
|
| Immunoassay | 2 | 2011 | 746 | 0.080 |
Why?
|
| Fibrinogen | 1 | 2012 | 891 | 0.080 |
Why?
|
| Transcription Factors | 3 | 2013 | 12168 | 0.080 |
Why?
|
| PPAR gamma | 2 | 2009 | 486 | 0.080 |
Why?
|
| Psychomotor Performance | 2 | 2009 | 1892 | 0.080 |
Why?
|
| Arousal | 1 | 2014 | 1180 | 0.080 |
Why?
|
| Predictive Value of Tests | 6 | 2020 | 15454 | 0.080 |
Why?
|
| Nutritional Status | 2 | 2002 | 1628 | 0.070 |
Why?
|
| Obesity, Abdominal | 1 | 2011 | 375 | 0.070 |
Why?
|
| Mice, Inbred C3H | 3 | 2005 | 915 | 0.070 |
Why?
|
| Cell Line | 5 | 2020 | 15597 | 0.070 |
Why?
|
| Solvents | 1 | 2009 | 298 | 0.070 |
Why?
|
| Drug Prescriptions | 1 | 2017 | 1668 | 0.070 |
Why?
|
| Transforming Growth Factor beta1 | 1 | 2012 | 638 | 0.070 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 3 | 2009 | 3252 | 0.070 |
Why?
|
| Anilides | 2 | 2017 | 413 | 0.070 |
Why?
|
| Diabetes Mellitus | 2 | 2018 | 5889 | 0.070 |
Why?
|
| Prostatism | 1 | 2007 | 16 | 0.070 |
Why?
|
| Regression Analysis | 4 | 2010 | 6340 | 0.070 |
Why?
|
| Metabolic Diseases | 1 | 2014 | 684 | 0.070 |
Why?
|
| Spermatogenesis | 1 | 2008 | 260 | 0.070 |
Why?
|
| Gender Identity | 2 | 2023 | 770 | 0.070 |
Why?
|
| Adipose Tissue, Brown | 1 | 2013 | 776 | 0.070 |
Why?
|
| Cell Division | 2 | 2006 | 4473 | 0.070 |
Why?
|
| Injections | 1 | 2010 | 840 | 0.070 |
Why?
|
| Health Policy | 2 | 2019 | 2698 | 0.070 |
Why?
|
| Keratinocytes | 1 | 2012 | 876 | 0.070 |
Why?
|
| Autoantibodies | 1 | 2016 | 2121 | 0.070 |
Why?
|
| Osmolar Concentration | 2 | 2011 | 657 | 0.070 |
Why?
|
| Drug Administration Routes | 2 | 2017 | 152 | 0.070 |
Why?
|
| Mothers | 1 | 1997 | 2209 | 0.070 |
Why?
|
| Cooperative Behavior | 1 | 2014 | 1514 | 0.070 |
Why?
|
| Remission, Spontaneous | 1 | 2007 | 384 | 0.070 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 2 | 2013 | 3800 | 0.070 |
Why?
|
| Body Height | 2 | 2007 | 1565 | 0.070 |
Why?
|
| Area Under Curve | 2 | 2014 | 1643 | 0.070 |
Why?
|
| Bone Marrow | 1 | 2017 | 2935 | 0.070 |
Why?
|
| Breast Feeding | 1 | 1995 | 1363 | 0.070 |
Why?
|
| Myogenin | 1 | 2006 | 54 | 0.070 |
Why?
|
| Social Support | 1 | 2016 | 2193 | 0.070 |
Why?
|
| Active Transport, Cell Nucleus | 1 | 2008 | 432 | 0.070 |
Why?
|
| Forkhead Transcription Factors | 1 | 2013 | 1625 | 0.070 |
Why?
|
| Metabolic Clearance Rate | 1 | 2006 | 363 | 0.060 |
Why?
|
| Respiration | 1 | 2012 | 1665 | 0.060 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2014 | 3740 | 0.060 |
Why?
|
| C-Reactive Protein | 2 | 2012 | 3858 | 0.060 |
Why?
|
| United States Food and Drug Administration | 2 | 2017 | 1673 | 0.060 |
Why?
|
| Feasibility Studies | 1 | 2017 | 5315 | 0.060 |
Why?
|
| Pressure | 1 | 2009 | 1172 | 0.060 |
Why?
|
| Apoptosis Regulatory Proteins | 1 | 2011 | 1151 | 0.060 |
Why?
|
| Health Surveys | 4 | 2020 | 4057 | 0.060 |
Why?
|
| Energy Metabolism | 2 | 2013 | 2907 | 0.060 |
Why?
|
| Aorta | 1 | 2013 | 2045 | 0.060 |
Why?
|
| Anti-HIV Agents | 1 | 2021 | 4573 | 0.060 |
Why?
|
| Nitriles | 2 | 2017 | 980 | 0.060 |
Why?
|
| Internet | 1 | 2017 | 3110 | 0.060 |
Why?
|
| Proliferating Cell Nuclear Antigen | 1 | 2006 | 284 | 0.060 |
Why?
|
| Dementia | 1 | 2020 | 2740 | 0.060 |
Why?
|
| Insulin-Like Growth Factor Binding Protein 3 | 1 | 2007 | 416 | 0.060 |
Why?
|
| Hyperlipidemias | 1 | 2010 | 772 | 0.060 |
Why?
|
| Transaminases | 1 | 2006 | 199 | 0.060 |
Why?
|
| Analgesics, Opioid | 3 | 2017 | 3837 | 0.060 |
Why?
|
| Magnetic Resonance Imaging | 7 | 2019 | 36743 | 0.060 |
Why?
|
| Urinary Tract Physiological Phenomena | 1 | 2004 | 11 | 0.060 |
Why?
|
| Protein Conformation | 2 | 2011 | 3956 | 0.060 |
Why?
|
| Inflammation Mediators | 1 | 2013 | 1892 | 0.060 |
Why?
|
| Antigens, Differentiation | 1 | 2008 | 921 | 0.060 |
Why?
|
| Goals | 1 | 2010 | 717 | 0.060 |
Why?
|
| Tyrosine | 1 | 2009 | 1427 | 0.060 |
Why?
|
| 17-alpha-Hydroxyprogesterone | 1 | 2024 | 22 | 0.060 |
Why?
|
| Biopsy | 2 | 2007 | 6793 | 0.060 |
Why?
|
| Case-Control Studies | 4 | 2024 | 22291 | 0.060 |
Why?
|
| Microscopy, Immunoelectron | 1 | 2004 | 316 | 0.060 |
Why?
|
| Endothelium, Vascular | 2 | 2013 | 4427 | 0.060 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2013 | 2062 | 0.060 |
Why?
|
| Weight Gain | 1 | 2014 | 2359 | 0.060 |
Why?
|
| Military Personnel | 1 | 2013 | 1261 | 0.060 |
Why?
|
| Specimen Handling | 1 | 2009 | 708 | 0.060 |
Why?
|
| Bone Morphogenetic Protein 7 | 2 | 2015 | 110 | 0.060 |
Why?
|
| Sweden | 2 | 2021 | 1382 | 0.060 |
Why?
|
| Administration, Oral | 1 | 2012 | 4030 | 0.060 |
Why?
|
| Structure-Activity Relationship | 1 | 2009 | 3055 | 0.050 |
Why?
|
| Health Personnel | 1 | 2017 | 3385 | 0.050 |
Why?
|
| DNA, Mitochondrial | 1 | 2009 | 872 | 0.050 |
Why?
|
| Protein Transport | 2 | 2008 | 1951 | 0.050 |
Why?
|
| Diagnostic Errors | 1 | 2011 | 1281 | 0.050 |
Why?
|
| Research | 2 | 2009 | 1979 | 0.050 |
Why?
|
| Transdermal Patch | 1 | 2023 | 51 | 0.050 |
Why?
|
| Outpatients | 1 | 2011 | 1600 | 0.050 |
Why?
|
| Child, Preschool | 8 | 2024 | 42669 | 0.050 |
Why?
|
| Health Status Indicators | 1 | 2008 | 969 | 0.050 |
Why?
|
| Appetite | 1 | 2005 | 247 | 0.050 |
Why?
|
| Tosyl Compounds | 1 | 2003 | 115 | 0.050 |
Why?
|
| Oxymetholone | 1 | 2002 | 8 | 0.050 |
Why?
|
| Chromosomes, Human, X | 2 | 2018 | 320 | 0.050 |
Why?
|
| Child | 9 | 2024 | 80917 | 0.050 |
Why?
|
| Mental Disorders | 1 | 2023 | 6874 | 0.050 |
Why?
|
| Blotting, Western | 3 | 2007 | 5027 | 0.050 |
Why?
|
| Sampling Studies | 2 | 2001 | 615 | 0.050 |
Why?
|
| Urinary Incontinence | 1 | 2007 | 490 | 0.050 |
Why?
|
| Vaginal Creams, Foams, and Jellies | 1 | 2022 | 62 | 0.050 |
Why?
|
| Urinary Incontinence, Stress | 1 | 2004 | 180 | 0.050 |
Why?
|
| Socioeconomic Factors | 4 | 2024 | 7852 | 0.050 |
Why?
|
| Stem Cells | 2 | 2007 | 3537 | 0.050 |
Why?
|
| Muscle Fibers, Slow-Twitch | 1 | 2002 | 52 | 0.050 |
Why?
|
| Comorbidity | 3 | 2019 | 10590 | 0.050 |
Why?
|
| Monitoring, Physiologic | 1 | 2010 | 1798 | 0.050 |
Why?
|
| Statistics, Nonparametric | 1 | 2008 | 2862 | 0.050 |
Why?
|
| Temperature | 1 | 2009 | 2234 | 0.050 |
Why?
|
| Tablets | 1 | 2022 | 149 | 0.050 |
Why?
|
| Protein Structure, Tertiary | 1 | 2009 | 3772 | 0.050 |
Why?
|
| Growth Differentiation Factor 15 | 1 | 2024 | 199 | 0.050 |
Why?
|
| Anatomy, Cross-Sectional | 1 | 2002 | 139 | 0.050 |
Why?
|
| Placebo Effect | 1 | 2006 | 517 | 0.050 |
Why?
|
| Apolipoproteins C | 1 | 2002 | 59 | 0.050 |
Why?
|
| Interleukin-6 | 1 | 2012 | 3228 | 0.050 |
Why?
|
| California | 1 | 2006 | 1438 | 0.050 |
Why?
|
| Weightlessness | 1 | 2002 | 103 | 0.050 |
Why?
|
| Tissue Fixation | 1 | 2003 | 246 | 0.050 |
Why?
|
| Mesoderm | 1 | 2005 | 679 | 0.050 |
Why?
|
| Osteoporosis | 1 | 2011 | 1605 | 0.050 |
Why?
|
| Boston | 2 | 2012 | 9374 | 0.050 |
Why?
|
| Dyslipidemias | 1 | 2009 | 873 | 0.050 |
Why?
|
| Multicenter Studies as Topic | 2 | 2018 | 1737 | 0.050 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2009 | 3814 | 0.050 |
Why?
|
| Genome-Wide Association Study | 4 | 2018 | 12795 | 0.050 |
Why?
|
| Lipoproteins, HDL | 1 | 2006 | 682 | 0.050 |
Why?
|
| Receptors, Notch | 1 | 2006 | 751 | 0.050 |
Why?
|
| Sweating | 1 | 2022 | 155 | 0.050 |
Why?
|
| Diarrhea, Infantile | 1 | 2001 | 100 | 0.050 |
Why?
|
| Residence Characteristics | 1 | 2011 | 2118 | 0.050 |
Why?
|
| Phenotype | 3 | 2019 | 16726 | 0.050 |
Why?
|
| Cell Size | 1 | 2003 | 626 | 0.050 |
Why?
|
| Behavior | 1 | 2004 | 542 | 0.050 |
Why?
|
| Pregnancy | 4 | 2024 | 30256 | 0.050 |
Why?
|
| Polymorphism, Single Nucleotide | 4 | 2018 | 16045 | 0.050 |
Why?
|
| Antiretroviral Therapy, Highly Active | 1 | 2009 | 1903 | 0.050 |
Why?
|
| Drug Monitoring | 2 | 2017 | 964 | 0.050 |
Why?
|
| Circadian Rhythm | 3 | 2007 | 2593 | 0.050 |
Why?
|
| Phosphorylation | 2 | 2011 | 8317 | 0.040 |
Why?
|
| Reproducibility of Results | 6 | 2020 | 20227 | 0.040 |
Why?
|
| Pharmaceutical Preparations | 1 | 2009 | 1088 | 0.040 |
Why?
|
| Wound Healing | 1 | 2012 | 2809 | 0.040 |
Why?
|
| Lower Extremity | 1 | 2008 | 1216 | 0.040 |
Why?
|
| Neurotic Disorders | 1 | 2000 | 77 | 0.040 |
Why?
|
| Apolipoprotein C-III | 1 | 2002 | 210 | 0.040 |
Why?
|
| Healthcare Disparities | 1 | 2016 | 3415 | 0.040 |
Why?
|
| Alzheimer Disease | 1 | 2022 | 8759 | 0.040 |
Why?
|
| Smoking | 2 | 2018 | 9092 | 0.040 |
Why?
|
| Apolipoproteins B | 1 | 2002 | 386 | 0.040 |
Why?
|
| Carbon Isotopes | 1 | 2021 | 458 | 0.040 |
Why?
|
| Peripheral Arterial Disease | 1 | 2011 | 1304 | 0.040 |
Why?
|
| Receptor Cross-Talk | 2 | 2012 | 118 | 0.040 |
Why?
|
| Space Flight | 1 | 2002 | 219 | 0.040 |
Why?
|
| Baltimore | 1 | 2020 | 233 | 0.040 |
Why?
|
| Men's Health | 1 | 2020 | 75 | 0.040 |
Why?
|
| Poverty Areas | 1 | 2001 | 268 | 0.040 |
Why?
|
| Delphi Technique | 1 | 2024 | 891 | 0.040 |
Why?
|
| Software | 1 | 2014 | 4478 | 0.040 |
Why?
|
| Lung | 1 | 2018 | 10099 | 0.040 |
Why?
|
| Alcohol Drinking | 1 | 2012 | 4045 | 0.040 |
Why?
|
| Pregnancy Trimester, First | 1 | 2024 | 917 | 0.040 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2010 | 6526 | 0.040 |
Why?
|
| Gas Chromatography-Mass Spectrometry | 2 | 2011 | 354 | 0.040 |
Why?
|
| Ion Channels | 2 | 2015 | 1043 | 0.040 |
Why?
|
| Hot Flashes | 1 | 2022 | 330 | 0.040 |
Why?
|
| RNA Interference | 1 | 2008 | 2832 | 0.040 |
Why?
|
| Peptides | 1 | 2011 | 4354 | 0.040 |
Why?
|
| Menstrual Cycle | 1 | 2022 | 546 | 0.040 |
Why?
|
| Denmark | 1 | 2021 | 776 | 0.040 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2011 | 4528 | 0.040 |
Why?
|
| Spectrometry, Fluorescence | 1 | 2021 | 694 | 0.040 |
Why?
|
| Biopsy, Needle | 1 | 2003 | 1622 | 0.040 |
Why?
|
| Menopause, Premature | 1 | 2019 | 124 | 0.040 |
Why?
|
| Mitochondrial Proteins | 2 | 2015 | 979 | 0.040 |
Why?
|
| Myocardium | 1 | 2011 | 4788 | 0.040 |
Why?
|
| Australia | 1 | 2021 | 1265 | 0.040 |
Why?
|
| Delivery of Health Care | 1 | 2016 | 5367 | 0.040 |
Why?
|
| Skin | 1 | 2012 | 4503 | 0.040 |
Why?
|
| Germ Cells | 1 | 2022 | 644 | 0.040 |
Why?
|
| Molecular Dynamics Simulation | 1 | 2021 | 427 | 0.040 |
Why?
|
| Polymorphism, Genetic | 2 | 2011 | 4249 | 0.040 |
Why?
|
| Abdomen | 1 | 2004 | 1136 | 0.040 |
Why?
|
| Medical Assistance | 1 | 2018 | 108 | 0.040 |
Why?
|
| Health | 2 | 2011 | 398 | 0.040 |
Why?
|
| Lung Volume Measurements | 1 | 2018 | 381 | 0.040 |
Why?
|
| Interviews as Topic | 2 | 2015 | 2741 | 0.040 |
Why?
|
| Communications Media | 1 | 2017 | 42 | 0.030 |
Why?
|
| Ovary | 2 | 2015 | 965 | 0.030 |
Why?
|
| Aminophenols | 1 | 2017 | 94 | 0.030 |
Why?
|
| Needs Assessment | 2 | 2016 | 1141 | 0.030 |
Why?
|
| Phytoestrogens | 1 | 2017 | 59 | 0.030 |
Why?
|
| Nuclear Proteins | 1 | 2011 | 5804 | 0.030 |
Why?
|
| Brachial Artery | 1 | 2018 | 373 | 0.030 |
Why?
|
| Vagina | 1 | 2022 | 850 | 0.030 |
Why?
|
| Kidney Failure, Chronic | 1 | 2009 | 2496 | 0.030 |
Why?
|
| Isoflavones | 1 | 2017 | 139 | 0.030 |
Why?
|
| Odds Ratio | 3 | 2016 | 9669 | 0.030 |
Why?
|
| Acetamides | 1 | 2017 | 259 | 0.030 |
Why?
|
| Pregnancy Trimester, Third | 1 | 2018 | 587 | 0.030 |
Why?
|
| Leptin | 1 | 2004 | 1599 | 0.030 |
Why?
|
| Intention to Treat Analysis | 1 | 2017 | 416 | 0.030 |
Why?
|
| Pyrrolidines | 1 | 2017 | 340 | 0.030 |
Why?
|
| Chromatography, High Pressure Liquid | 2 | 2010 | 1534 | 0.030 |
Why?
|
| Adenine | 1 | 2021 | 995 | 0.030 |
Why?
|
| Maternal Age | 1 | 2018 | 805 | 0.030 |
Why?
|
| Educational Status | 1 | 2003 | 2515 | 0.030 |
Why?
|
| Fatty Acids | 1 | 2003 | 1812 | 0.030 |
Why?
|
| Estrous Cycle | 1 | 2015 | 65 | 0.030 |
Why?
|
| Terminology as Topic | 1 | 2022 | 1542 | 0.030 |
Why?
|
| Disease Models, Animal | 1 | 2014 | 18349 | 0.030 |
Why?
|
| Urban Health | 1 | 1997 | 535 | 0.030 |
Why?
|
| Asymptomatic Diseases | 1 | 2018 | 590 | 0.030 |
Why?
|
| Meta-Analysis as Topic | 1 | 2020 | 1363 | 0.030 |
Why?
|
| Calcium, Dietary | 1 | 2018 | 533 | 0.030 |
Why?
|
| Stress, Psychological | 1 | 2010 | 4530 | 0.030 |
Why?
|
| Weaning | 1 | 1995 | 102 | 0.030 |
Why?
|
| Sound Spectrography | 1 | 2015 | 114 | 0.030 |
Why?
|
| Regional Blood Flow | 1 | 2018 | 1500 | 0.030 |
Why?
|
| Geriatrics | 1 | 2019 | 394 | 0.030 |
Why?
|
| ROC Curve | 2 | 2014 | 3628 | 0.030 |
Why?
|
| Long-Term Care | 1 | 2019 | 631 | 0.030 |
Why?
|
| Infant | 5 | 2001 | 36535 | 0.030 |
Why?
|
| Blood Glucose Self-Monitoring | 1 | 2018 | 475 | 0.030 |
Why?
|
| Gene Knockdown Techniques | 1 | 2019 | 1606 | 0.030 |
Why?
|
| Leadership | 1 | 2024 | 1397 | 0.030 |
Why?
|
| Congresses as Topic | 1 | 2019 | 812 | 0.030 |
Why?
|
| Decision Making | 1 | 2008 | 3953 | 0.030 |
Why?
|
| Vasodilation | 1 | 2018 | 967 | 0.030 |
Why?
|
| Membrane Proteins | 1 | 2011 | 7876 | 0.030 |
Why?
|
| Diabetic Foot | 1 | 2018 | 382 | 0.030 |
Why?
|
| Triglycerides | 1 | 2002 | 2464 | 0.030 |
Why?
|
| Prognosis | 4 | 2020 | 30010 | 0.030 |
Why?
|
| Sodium Chloride, Dietary | 1 | 1996 | 301 | 0.030 |
Why?
|
| Food Deprivation | 1 | 2013 | 114 | 0.030 |
Why?
|
| Forecasting | 1 | 2003 | 2945 | 0.030 |
Why?
|
| Sample Size | 1 | 2017 | 846 | 0.030 |
Why?
|
| Retrospective Studies | 5 | 2024 | 81762 | 0.030 |
Why?
|
| Starvation | 1 | 2013 | 141 | 0.030 |
Why?
|
| Allosteric Regulation | 1 | 2014 | 426 | 0.030 |
Why?
|
| Aorta, Abdominal | 1 | 2016 | 627 | 0.030 |
Why?
|
| Health Priorities | 1 | 2016 | 380 | 0.030 |
Why?
|
| Sequence Analysis, Protein | 1 | 2014 | 264 | 0.030 |
Why?
|
| Self Concept | 1 | 2018 | 1043 | 0.030 |
Why?
|
| Mendelian Randomization Analysis | 1 | 2018 | 1040 | 0.020 |
Why?
|
| Thrombosis | 1 | 2006 | 2957 | 0.020 |
Why?
|
| PAX7 Transcription Factor | 1 | 2011 | 55 | 0.020 |
Why?
|
| Databases, Protein | 1 | 2014 | 390 | 0.020 |
Why?
|
| Amino Acid Motifs | 1 | 2014 | 930 | 0.020 |
Why?
|
| Voice Disorders | 1 | 2015 | 286 | 0.020 |
Why?
|
| Ventricular Remodeling | 1 | 2019 | 1281 | 0.020 |
Why?
|
| Actin-Related Protein 2-3 Complex | 1 | 2011 | 61 | 0.020 |
Why?
|
| Genotype | 2 | 2018 | 13045 | 0.020 |
Why?
|
| Rats | 4 | 2011 | 23760 | 0.020 |
Why?
|
| Patient Satisfaction | 1 | 2023 | 3488 | 0.020 |
Why?
|
| Hypophysectomy | 1 | 2010 | 114 | 0.020 |
Why?
|
| Consensus Sequence | 1 | 2011 | 363 | 0.020 |
Why?
|
| Alleles | 2 | 2012 | 6894 | 0.020 |
Why?
|
| Observer Variation | 1 | 2017 | 2622 | 0.020 |
Why?
|
| Age Distribution | 2 | 2006 | 2873 | 0.020 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2021 | 3780 | 0.020 |
Why?
|
| Mental Recall | 1 | 2017 | 1226 | 0.020 |
Why?
|
| Drug Approval | 1 | 2017 | 821 | 0.020 |
Why?
|
| Heart Rate | 2 | 2014 | 4214 | 0.020 |
Why?
|
| RNA, Small Interfering | 2 | 2010 | 3428 | 0.020 |
Why?
|
| Sulfotransferases | 1 | 2011 | 150 | 0.020 |
Why?
|
| Amino Acid Sequence | 1 | 2022 | 13421 | 0.020 |
Why?
|
| Pregnancy Outcome | 1 | 2021 | 2972 | 0.020 |
Why?
|
| Health Care Surveys | 1 | 2017 | 2434 | 0.020 |
Why?
|
| Social Class | 2 | 2007 | 2008 | 0.020 |
Why?
|
| Aryl Hydrocarbon Hydroxylases | 1 | 2011 | 246 | 0.020 |
Why?
|
| Scopolamine | 1 | 1990 | 93 | 0.020 |
Why?
|
| Animals, Newborn | 1 | 2015 | 2678 | 0.020 |
Why?
|
| Leucine | 1 | 2011 | 547 | 0.020 |
Why?
|
| Aorta, Thoracic | 1 | 2016 | 1110 | 0.020 |
Why?
|
| Catalysis | 1 | 2011 | 768 | 0.020 |
Why?
|
| Cardiovascular Physiological Phenomena | 1 | 2011 | 241 | 0.020 |
Why?
|
| Physical Education and Training | 1 | 2009 | 102 | 0.020 |
Why?
|
| Computer Simulation | 2 | 2014 | 6283 | 0.020 |
Why?
|
| Contraceptives, Oral | 1 | 2011 | 560 | 0.020 |
Why?
|
| Genetic Heterogeneity | 1 | 2012 | 736 | 0.020 |
Why?
|
| Proteins | 1 | 2023 | 6009 | 0.020 |
Why?
|
| Fluorescence Resonance Energy Transfer | 1 | 2011 | 414 | 0.020 |
Why?
|
| Hyperinsulinism | 1 | 2011 | 402 | 0.020 |
Why?
|
| Family Health | 1 | 2013 | 1255 | 0.020 |
Why?
|
| Receptor, IGF Type 1 | 1 | 2010 | 384 | 0.020 |
Why?
|
| Kruppel-Like Transcription Factors | 1 | 2011 | 507 | 0.020 |
Why?
|
| Hyperglycemia | 1 | 2017 | 1388 | 0.020 |
Why?
|
| Health Services Needs and Demand | 1 | 2016 | 1406 | 0.020 |
Why?
|
| Receptors, Transforming Growth Factor beta | 1 | 2009 | 304 | 0.020 |
Why?
|
| Metabolic Networks and Pathways | 1 | 2012 | 801 | 0.020 |
Why?
|
| Insulin-Like Growth Factor Binding Protein 4 | 1 | 2007 | 24 | 0.020 |
Why?
|
| Urologic Diseases | 1 | 2010 | 246 | 0.020 |
Why?
|
| Osteoporosis, Postmenopausal | 1 | 2011 | 399 | 0.020 |
Why?
|
| Fatty Acid-Binding Proteins | 1 | 2009 | 293 | 0.020 |
Why?
|
| Sperm Motility | 1 | 2008 | 265 | 0.020 |
Why?
|
| Premenopause | 1 | 2011 | 1039 | 0.020 |
Why?
|
| Tuberculosis | 1 | 2000 | 2029 | 0.020 |
Why?
|
| Memory | 1 | 2017 | 2208 | 0.020 |
Why?
|
| Glucagon | 1 | 2009 | 535 | 0.020 |
Why?
|
| Sleep Deprivation | 1 | 2013 | 848 | 0.020 |
Why?
|
| Epididymis | 1 | 2008 | 227 | 0.020 |
Why?
|
| SKP Cullin F-Box Protein Ligases | 1 | 2007 | 174 | 0.020 |
Why?
|
| Chorionic Gonadotropin | 1 | 2008 | 458 | 0.020 |
Why?
|
| Rats, Sprague-Dawley | 2 | 2010 | 8128 | 0.020 |
Why?
|
| Ventricular Function, Left | 1 | 2019 | 3941 | 0.020 |
Why?
|
| Adipose Tissue, White | 1 | 2009 | 371 | 0.020 |
Why?
|
| Linkage Disequilibrium | 1 | 2011 | 1997 | 0.020 |
Why?
|
| Translocation, Genetic | 1 | 2012 | 1394 | 0.020 |
Why?
|
| Waist-Hip Ratio | 1 | 2007 | 520 | 0.020 |
Why?
|
| Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 1 | 2008 | 325 | 0.020 |
Why?
|
| Electrocardiography | 2 | 2017 | 6412 | 0.020 |
Why?
|
| Models, Statistical | 1 | 2020 | 5107 | 0.020 |
Why?
|
| Anxiety | 1 | 2020 | 4672 | 0.020 |
Why?
|
| Postural Balance | 1 | 2010 | 639 | 0.020 |
Why?
|
| Testis | 1 | 2008 | 783 | 0.020 |
Why?
|
| Laboratories | 1 | 2009 | 463 | 0.020 |
Why?
|
| Guideline Adherence | 1 | 2015 | 2235 | 0.020 |
Why?
|
| Coronary Angiography | 1 | 2017 | 4541 | 0.020 |
Why?
|
| DNA-Binding Proteins | 2 | 2013 | 9615 | 0.010 |
Why?
|
| Dexamethasone | 2 | 2003 | 1965 | 0.010 |
Why?
|
| Lipid Metabolism | 1 | 2013 | 1904 | 0.010 |
Why?
|
| MyoD Protein | 1 | 2005 | 143 | 0.010 |
Why?
|
| Mice, Inbred Strains | 1 | 2007 | 1765 | 0.010 |
Why?
|
| Gene Regulatory Networks | 1 | 2013 | 1752 | 0.010 |
Why?
|
| Infant, Newborn | 2 | 1995 | 26422 | 0.010 |
Why?
|
| Spermatozoa | 1 | 2008 | 632 | 0.010 |
Why?
|
| Poverty | 1 | 1996 | 2720 | 0.010 |
Why?
|
| Vitamin D | 1 | 2018 | 3311 | 0.010 |
Why?
|
| Nonlinear Dynamics | 1 | 2006 | 493 | 0.010 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2015 | 3610 | 0.010 |
Why?
|
| Myoblasts | 1 | 2005 | 234 | 0.010 |
Why?
|
| Linear Models | 1 | 2014 | 5884 | 0.010 |
Why?
|
| Rural Population | 1 | 1994 | 2325 | 0.010 |
Why?
|
| Primary Health Care | 1 | 2020 | 4746 | 0.010 |
Why?
|
| Genetic Association Studies | 1 | 2013 | 2744 | 0.010 |
Why?
|
| Azacitidine | 1 | 2005 | 336 | 0.010 |
Why?
|
| Cattle | 1 | 2009 | 3819 | 0.010 |
Why?
|
| Neuropsychological Tests | 1 | 2016 | 7140 | 0.010 |
Why?
|
| Interdisciplinary Communication | 1 | 2009 | 937 | 0.010 |
Why?
|
| Drug Combinations | 1 | 2009 | 2089 | 0.010 |
Why?
|
| Protein Isoforms | 1 | 2007 | 1715 | 0.010 |
Why?
|
| Binding Sites | 1 | 2011 | 6020 | 0.010 |
Why?
|
| Musculoskeletal Physiological Phenomena | 1 | 2002 | 31 | 0.010 |
Why?
|
| Mifepristone | 1 | 2003 | 151 | 0.010 |
Why?
|
| Video Recording | 1 | 2007 | 976 | 0.010 |
Why?
|
| Sex Characteristics | 1 | 2012 | 2650 | 0.010 |
Why?
|
| Databases, Factual | 1 | 2017 | 8080 | 0.010 |
Why?
|
| Rats, Inbred F344 | 1 | 2002 | 826 | 0.010 |
Why?
|
| Homeodomain Proteins | 1 | 2011 | 2429 | 0.010 |
Why?
|
| Yogurt | 1 | 2001 | 71 | 0.010 |
Why?
|
| Receptors, Glucocorticoid | 1 | 2003 | 309 | 0.010 |
Why?
|
| Subcellular Fractions | 1 | 2002 | 525 | 0.010 |
Why?
|
| Models, Molecular | 1 | 2011 | 5403 | 0.010 |
Why?
|
| Tomography, X-Ray Computed | 2 | 2017 | 20760 | 0.010 |
Why?
|
| Algorithms | 2 | 2014 | 14164 | 0.010 |
Why?
|
| Stroke | 1 | 2023 | 9755 | 0.010 |
Why?
|
| DNA Primers | 1 | 2005 | 2828 | 0.010 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2011 | 2909 | 0.010 |
Why?
|
| Data Interpretation, Statistical | 1 | 2010 | 2709 | 0.010 |
Why?
|
| Blotting, Northern | 1 | 2002 | 1550 | 0.010 |
Why?
|
| Academic Medical Centers | 1 | 2010 | 2784 | 0.010 |
Why?
|
| Pain | 1 | 2015 | 5100 | 0.010 |
Why?
|
| Polymerase Chain Reaction | 1 | 2009 | 6082 | 0.010 |
Why?
|
| Respiratory Function Tests | 1 | 2004 | 1695 | 0.010 |
Why?
|
| Risk | 1 | 2011 | 9613 | 0.010 |
Why?
|
| Transfection | 1 | 2007 | 5755 | 0.010 |
Why?
|
| Nutrition Assessment | 1 | 2002 | 740 | 0.010 |
Why?
|
| Exercise Tolerance | 1 | 2004 | 846 | 0.010 |
Why?
|
| Protein Binding | 1 | 2011 | 9343 | 0.010 |
Why?
|
| Milk | 1 | 2001 | 438 | 0.010 |
Why?
|
| Psychology | 1 | 2000 | 353 | 0.010 |
Why?
|
| Tissue Distribution | 1 | 2002 | 2300 | 0.010 |
Why?
|
| Staining and Labeling | 1 | 2002 | 1081 | 0.010 |
Why?
|
| Histocompatibility Antigens Class II | 1 | 2002 | 1441 | 0.010 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2019 | 18065 | 0.010 |
Why?
|
| Data Collection | 1 | 2006 | 3327 | 0.010 |
Why?
|
| Immune System | 1 | 2002 | 799 | 0.010 |
Why?
|
| Fasting | 1 | 2002 | 1610 | 0.010 |
Why?
|
| Deficiency Diseases | 1 | 1996 | 74 | 0.010 |
Why?
|
| Cell Cycle Proteins | 1 | 2007 | 3445 | 0.010 |
Why?
|
| Nerve Tissue Proteins | 1 | 2008 | 4413 | 0.010 |
Why?
|
| DNA | 1 | 2009 | 7214 | 0.010 |
Why?
|
| Proportional Hazards Models | 1 | 2010 | 12543 | 0.010 |
Why?
|
| Coronary Disease | 1 | 2009 | 5919 | 0.010 |
Why?
|
| Food, Fortified | 1 | 1996 | 189 | 0.010 |
Why?
|
| Heart Ventricles | 1 | 2007 | 3841 | 0.010 |
Why?
|
| Cognition Disorders | 1 | 2009 | 3980 | 0.010 |
Why?
|
| Base Sequence | 1 | 2005 | 12421 | 0.010 |
Why?
|
| Multivariate Analysis | 1 | 2006 | 12077 | 0.010 |
Why?
|
| Stroke Volume | 1 | 2007 | 5622 | 0.010 |
Why?
|
| Internship and Residency | 1 | 2010 | 5953 | 0.010 |
Why?
|
| Pilot Projects | 1 | 2001 | 8741 | 0.000 |
Why?
|
| Autonomic Nervous System | 1 | 1990 | 707 | 0.000 |
Why?
|